Our sister site, Drug Delivery Business News, reports today that Sequel and Senseonics agreed to integrate the latter’s year-long continuous glucose monitor (CGM) into the twiist automated insulin delivery system. This collaboration would make twiist the first AID system compatible with Eversense 365, the world’s first and only one-year CGM.
twiist, combined with the twiist Loop algorithm, directly measures the volume of insulin delivered with every microdose. It offers the capability and flexibility to address each patient’s individual dosing needs. Sequel’s system utilizes sound waves that measure each pulse of insulin. This enables precision and helps understand exactly how much insulin the patient receives in a dose.
Senseonics, meanwhile, brought the first year-long CGM to market last year, launching Eversense 365 with its global distribution partner, Ascensia Diabetes Care, in October 2024. The system also received clearance as an integrated CGM (iCGM) system, meaning it can work with compatible medical devices. Those include insulin pumps as part of automated insulin delivery systems.
Read the full story at our sister site, Drug Delivery Business News.
